Ameritas Investment Partners’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.6K | Hold |
1,121
| – | – | ﹤0.01% | 2604 |
|
|
2025
Q4 | $22K | Hold |
1,121
| – | – | ﹤0.01% | 2594 |
|
|
2025
Q3 | $30.9K | Hold |
1,121
| – | – | ﹤0.01% | 2467 |
|
|
2025
Q2 | $34.2K | Hold |
1,121
| – | – | ﹤0.01% | 2405 |
|
|
2025
Q1 | $30.2K | Hold |
1,121
| – | – | ﹤0.01% | 2377 |
|
|
2024
Q4 | $40.2K | Hold |
1,121
| – | – | ﹤0.01% | 2316 |
|
|
2024
Q3 | $42.5K | Hold |
1,121
| – | – | ﹤0.01% | 2283 |
|
|
2024
Q2 | $50.7K | Hold |
1,121
| – | – | ﹤0.01% | 2138 |
|
|
2024
Q1 | $54.4K | Hold |
1,121
| – | – | ﹤0.01% | 2099 |
|
|
2023
Q4 | $60.1K | Hold |
1,121
| – | – | ﹤0.01% | 2053 |
|
|
2023
Q3 | $65.7K | Buy |
1,121
+194
| +21% | +$12.1K | ﹤0.01% | 1935 |
|
|
2023
Q2 | $58.4K | Hold |
927
| – | – | ﹤0.01% | 1950 |
|
|
2023
Q1 | $58.3K | Hold |
927
| – | – | ﹤0.01% | 1877 |
|
|
2022
Q4 | $52.8K | Hold |
927
| – | – | ﹤0.01% | 2017 |
|
|
2022
Q3 | $51K | Hold |
927
| – | – | ﹤0.01% | 1968 |
|
|
2022
Q2 | $67K | Hold |
927
| – | – | ﹤0.01% | 1800 |
|
|
2022
Q1 | $74K | Hold |
927
| – | – | ﹤0.01% | 1827 |
|
|
2021
Q4 | $94K | Sell |
927
-95
| -9% | -$9.48K | ﹤0.01% | 1724 |
|
|
2021
Q3 | $94K | Hold |
1,022
| – | – | ﹤0.01% | 1732 |
|
|
2021
Q2 | $105K | Hold |
1,022
| – | – | ﹤0.01% | 1698 |
|
|
2021
Q1 | $100K | Hold |
1,022
| – | – | ﹤0.01% | 1675 |
|
|
2020
Q4 | $79K | Hold |
1,022
| – | – | ﹤0.01% | 1706 |
|
|
2020
Q3 | $75K | Hold |
1,022
| – | – | ﹤0.01% | 1609 |
|
|
2020
Q2 | $75K | Sell |
1,022
-130
| -11% | -$10.2K | ﹤0.01% | 1593 |
|
|
2020
Q1 | $67K | Hold |
1,152
| – | – | ﹤0.01% | 1501 |
|
|
2019
Q4 | $90K | Hold |
1,152
| – | – | ﹤0.01% | 1576 |
|
|
2019
Q3 | $79K | Hold |
1,152
| – | – | ﹤0.01% | 1617 |
|
|
2019
Q2 | $92K | Buy |
1,152
+134
| +13% | +$10.6K | ﹤0.01% | 1547 |
|
|
2019
Q1 | $85K | Hold |
1,018
| – | – | ﹤0.01% | 1575 |
|
|
2018
Q4 | $120K | Hold |
1,018
| – | – | 0.01% | 1264 |
|
|
2018
Q3 | $123K | Hold |
1,018
| – | – | 0.01% | 1407 |
|
|
2018
Q2 | $117K | Hold |
1,018
| – | – | 0.01% | 1439 |
|
|
2018
Q1 | $87K | Hold |
1,018
| – | – | ﹤0.01% | 1579 |
|
|
2017
Q4 | $75K | Hold |
1,018
| – | – | ﹤0.01% | 1681 |
|
|
2017
Q3 | $60K | Hold |
1,018
| – | – | ﹤0.01% | 1773 |
|
|
2017
Q2 | $65K | Buy |
1,018
+196
| +24% | +$12.1K | ﹤0.01% | 1732 |
|
|
2017
Q1 | $47K | Buy |
+822
| New | +$49.1K | ﹤0.01% | 1896 |
|
Other funds holding USNA
NCM
VCM
VPM
Ameritas Investment Partners's USNA Position: Q1 2026 in Review
Ameritas Investment Partners held its Usana Health Sciences (USNA) position steady in Q1 2026 at 1,121 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2604.
Ameritas Investment Partners first reported a position in USNA in Q1 2017 and has held it in 37 quarters since. The position peaked at $123K in Q3 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- Ameritas Investment Partners held 1,121 shares of Usana Health Sciences worth $19.6K as of Q1 2026.
- Ameritas Investment Partners left its Usana Health Sciences share count unchanged in Q1 2026.
- Usana Health Sciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2604 holding.
- Ameritas Investment Partners first reported a position in Usana Health Sciences in Q1 2017 and has held it in 37 quarters since.
- Ameritas Investment Partners's Usana Health Sciences position peaked at $123K in Q3 2018.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.